Today: 23 March 2026
Browse Category

NASDAQ:RIGL 5 November 2025

Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Rigel Pharmaceuticals shares jumped over 30% to around $38 on Nov. 5, 2025, after reporting Q3 revenue of $69.5 million, up 25% year-over-year. Net income reached $27.9 million, and the company raised its 2025 revenue guidance to $285–$290 million. Product sales, led by Tavalisse, surged 65%. Rigel also announced new clinical milestones and ongoing global partnerships.

Stock Market Today

  • Bitcoin Holds $70,000, Ethereum Enters Buy Zone, Nasdaq Gains SEC Nod for Tokenized Stocks
    March 23, 2026, 12:01 AM EDT. Bitcoin held firm near the $70,000 level despite $90 million ETF outflows, marking a crucial juncture for the flagship cryptocurrency. Ethereum entered a 'generational buy zone' as its market-to-realized value ratio hit levels historically preceding major bull runs. Meanwhile, Nasdaq received SEC approval to list tokenized versions of stocks, expanding digital trading options to Russell 1000 firms and key ETFs. SEC Chair Paul Atkins unveiled a new regulatory framework, clarifying that stablecoins, NFTs, and certain digital assets generally fall outside securities laws. Morgan Stanley launched its Bitcoin ETF under the ticker MSBT, backed by a $1 million seed and supported by BNY Mellon and Coinbase as custodian and broker.
Go toTop